Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass
NCT: NCT07078370 · ENROLLING_BY_INVITATION
Brief Summary
To assess safety and feasibility of a coronary bypass created with Vascudyne Acellular Tissue Engineered Vessel (ATEV) with External Support Structure (ESS) in patients requiring multi vessel coronary artery bypass grafting (CABG).
Frequently Asked Questions
What is Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass?
Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass is a clinical trial registered under NCT07078370. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07078370?
The current status of NCT07078370 (Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass) is: ENROLLING_BY_INVITATION.
When did Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass start?
Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass started on 2025-08-28.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.